Transderm Scop en es it fr

Transderm Scop Brand names, Transderm Scop Analogs

Transderm Scop Brand Names Mixture

  • Biosol-M-Aquadrops liq (methscopolamine bromide + neomycin sulfate)
  • Neomix-pamine Scour Bolus (methscopolamine bromide + neomycin sulfate)
  • Neomix-pamine Solution (methscopolamine bromide + neomycin sulfate)
  • Neosol M Aquadrops (methscopolamine bromide + neomycin)
  • Scour solution (methscopolamine bromide + neomycin)
  • Scour solution coop (methscopolamine bromide + neomycin)

Transderm Scop Chemical_Formula


Transderm Scop RX_link

Transderm Scop fda sheet

Transderm_Scop FDA

Transderm Scop msds (material safety sheet)

Transderm Scop Synthesis Reference

No information avaliable

Transderm Scop Molecular Weight

397.089 g/mol

Transderm Scop Melting Point

225 oC

Transderm Scop H2O Solubility

Freely soluble

Transderm Scop State


Transderm Scop LogP


Transderm Scop Dosage Forms

Tablet (2.5mg, 5mg)

Transderm Scop Indication

Used as adjunctive therapy for the treatment of peptic ulcer. Also used to treat nausea and vomiting due to motion sickness.

Transderm Scop Pharmacology

Methscopolamine bromide is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine and acts by blocking the muscarinic acetylcholine receptors and is thus classified as an anticholinergic. Methscopolamine bromide has many uses including the prevention of motion sickness. It is not clear how methscopolamine bromide prevents nausea and vomiting due to motion sickness. The vestibular part of the ear is very important for balance. When a person becomes disoriented due to motion, the vestibule sends a signal through nerves to the vomiting center in the brain, and vomiting occurs. Acetylcholine is a chemical that nerves use to transmit messages to each other. It is believe that methscopolamine bromide prevents communication between the nerves of the vestibule and the vomiting center in the brain by blocking the action of acetylcholine. Methscopolamine bromide also may work directly on the vomiting center. Methscopolamine bromide must be taken before the onset of motion sickness to be effective.

Transderm Scop Absorption

Poorly and unreliably absorbed, total absorption is 10-25%.

Transderm Scop side effects and Toxicity

Symptoms of a methscopolamine bromide overdose include headache, nausea, vomiting, dry mouth, difficulty swallowing, blurred vision, dilated pupils, hot, dry skin, dizziness; drowsiness, confusion, anxiety, seizures, weak pulse, and an irregular heartbeat. In addition, a curare-like action may occur, i.e., neuromuscular blockade leading to muscular weakness and possible paralysis.

Transderm Scop Patient Information

No information avaliable

Transderm Scop Organisms Affected

Humans and other mammals